Morphic Holding, Inc. (MORF)
NASDAQ: MORF · IEX Real-Time Price · USD
56.52
+0.20 (0.36%)
At close: Jul 19, 2024, 4:00 PM
56.75
+0.23 (0.41%)
Pre-market: Jul 22, 2024, 8:56 AM EDT
Morphic Holding Revenue
In the year 2023, Morphic Holding had annual revenue of $521.00K.
Revenue (ttm)
$521.00K
Revenue Growth
-99.26%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
121
Market Cap
2.83B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 521.00K | -70.29M | -99.26% |
Dec 31, 2022 | 70.81M | 51.01M | 257.72% |
Dec 31, 2021 | 19.79M | -25.15M | -55.96% |
Dec 31, 2020 | 44.95M | 27.97M | 164.74% |
Dec 31, 2019 | 16.98M | 13.62M | 405.57% |
Dec 31, 2018 | 3.36M | - | - |
Dec 31, 2017 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch Health Companies | 8.97B |
agilon health | 4.78B |
Envista Holdings | 2.56B |
LivaNova | 1.19B |
ACADIA Pharmaceuticals | 813.81M |
Tandem Diabetes Care | 770.01M |
Azenta | 651.76M |
MorphoSys AG | 264.75M |
MORF News
- 1 day ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHCR, MORF on Behalf of Shareholders - GlobeNewsWire
- 2 days ago - MORPHIC HOLDING INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Morphic Holding, Inc. - MORF - Business Wire
- 2 days ago - SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Morphic Holding, Inc. – MORF - GlobeNewsWire
- 10 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SPR, MORF on Behalf of Shareholders - GlobeNewsWire
- 12 days ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MORF, DM on Behalf of Shareholders - PRNewsWire
- 13 days ago - Shareholder Alert: Ademi LLP investigates whether Morphic Holding, Inc. has obtained a Fair Price for its Public Shareholders - PRNewsWire
- 13 days ago - Eli Lilly Buys Morphic for $3.2B - Investopedia
- 13 days ago - Eli Lilly Buys Bowel Disease Drug Developer Morphic In $3.2 Billion Deal - Forbes